Synchron System Hemoglobin Alc Reagent
by Beckman Instruments, Inc. 510(k)
Active
510(k) K973696
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK973696 | Date24 Nov 1997 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
-
- Terminated Z-1156-04
Values for ApoB were not properly assigned on the package insert. Customers were not able to recover the analyte within the stated values.
-
- Terminated Z-1155-04
LDL Cholesterol component in controls are unstable.
Specification
- 510(k) Number
- FDA Product Code
- LCP
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.7470
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Synchron System Hemoglobin A1c Reagent is an in vitro diagnostic assay designed to measure glycosylated hemoglobin (HbA1c) levels in human whole blood. It functions as a reagent for use with the Synchron Clinical Systems to quantify HbA1c concentration as a percentage of total hemoglobin, aiding in the diagnosis and management of diabetes.
This reagent is intended for clinical laboratory use and is supplied as a kit for processing whole blood samples. It is classified as a Class II medical device under FDA regulations (864.7470) and holds a 510(k) clearance for substantial equivalence in hematology applications. The product is not described as single-use or reusable, nor are MRI safety or sterility specifications provided in the available data.
Other devices from Beckman Instruments, Inc.
Questions
AI-generated answers, 19 Sep 2026
What is the Synchron System Hemoglobin A1c Reagent used for in a clinical setting?
The Synchron System Hemoglobin A1c Reagent is designed to measure glycosylated hemoglobin (HbA1c) levels in human whole blood. HbA1c testing helps clinicians diagnose and monitor diabetes by quantifying the percentage of hemoglobin bound to glucose over time, providing insight into long-term blood sugar control.
How is the Synchron System Hemoglobin A1c Reagent supplied, and is it intended for single-use or reuse?
The reagent is supplied as a kit for processing whole blood samples, intended for use with the Synchron Clinical Systems. The data does not specify whether it is single-use or reusable, so its intended use should be confirmed with the manufacturer or local protocols.
What regulatory pathway was followed for the FDA clearance of this device?
The Synchron System Hemoglobin A1c Reagent received FDA clearance through a 510(k) submission, classified as a Traditional pathway. It was determined to be substantially equivalent to a predicate device under the Hematology advisory committee (HE) and falls under FDA classification 864.7470 for glycosylated hemoglobin assays.
Are there multiple versions or models of this reagent, and how would I identify the correct one for my lab?
The data lists multiple FEI numbers (e.g., 3043654757, 3003422726) associated with this reagent, which may correspond to different lot codes or configurations. To ensure compatibility, verify the exact FEI number or registration number on your kit against your lab’s inventory or consult Beckman Instruments for model-specific guidance.